Gossamer Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gossamer Bio and other ETFs, options, and stocks.About GOSS
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions.
CEOFaheem Hasnain
CEOFaheem Hasnain
Employees145
Employees145
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees145
Employees145
GOSS Key Statistics
Market cap604.42M
Market cap604.42M
Price-Earnings ratio-3.65
Price-Earnings ratio-3.65
Dividend yield—
Dividend yield—
Average volume2.54M
Average volume2.54M
High today$2.69
High today$2.69
Low today$2.50
Low today$2.50
Open price$2.65
Open price$2.65
Volume2.32M
Volume2.32M
52 Week high$3.60
52 Week high$3.60
52 Week low$0.6617
52 Week low$0.6617
Stock Snapshot
Gossamer Bio(GOSS) stock is priced at $2.52, giving the company a market capitalization of 604.42M. It carries a P/E multiple of -3.65.
During the trading session on 2025-11-14, Gossamer Bio(GOSS) shares reached a daily high of $2.69 and a low of $2.50. At a current price of $2.52, the stock is +0.8% higher than the low and still -6.3% under the high.
Trading volume for Gossamer Bio(GOSS) stock has reached 2.32M, versus its average volume of 2.54M.
Over the past 52 weeks, Gossamer Bio(GOSS) stock has traded between a high of $3.60 and a low of $0.66.
Over the past 52 weeks, Gossamer Bio(GOSS) stock has traded between a high of $3.60 and a low of $0.66.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own GOSS. This list is generated using Robinhood data, and it’s not a recommendation.